Suchergebnisse - "Liao, Mingxiang"

PubPharm (74)

11

Pharmacokinetics and safety of rucaparib in patients with advanced solid tumors and hepatic impairment

enthalten in: Cancer chemotherapy and pharmacology | 2021

von Grechko, N. | Skarbova, V. | Tomaszewska-Kiecana, M. | +10

12

A phase 1, open-label, drug–drug interaction study of rucaparib with rosuvastatin and oral contraceptives in patients with advanced solid tumors

enthalten in: Cancer chemotherapy and pharmacology | 2021

von Liao, M. | Jeziorski, K. | Tomaszewska-Kiecana, M. | +12

13

A phase 1, open-label, drug–drug interaction study of rucaparib with rosuvastatin and oral contraceptives in patients with advanced solid tumors

enthalten in: Cancer chemotherapy and pharmacology | 2021

von Liao, M. | Jeziorski, K. | Tomaszewska-Kiecana, M. | +12

14

A phase 1, open-label, drug–drug interaction study of rucaparib with rosuvastatin and oral contraceptives in patients with advanced solid tumors

enthalten in: Cancer chemotherapy and pharmacology | 2021

von Liao, M. | Jeziorski, K. | Tomaszewska-Kiecana, M. | +12

15

Pharmacokinetics and safety of rucaparib in patients with advanced solid tumors and hepatic impairment

enthalten in: Cancer chemotherapy and pharmacology | 2021

von Grechko, N. | Skarbova, V. | Tomaszewska-Kiecana, M. | +10

16

Pharmacokinetics and safety of rucaparib in patients with advanced solid tumors and hepatic impairment

enthalten in: Cancer chemotherapy and pharmacology | 2021

von Grechko, N. | Skarbova, V. | Tomaszewska-Kiecana, M. | +10

17

Pharmacokinetics and safety of rucaparib in patients with advanced solid tumors and hepatic impairment

enthalten in: Cancer chemotherapy and pharmacology | 2021

von Grechko, N. | Skarbova, V. | Tomaszewska-Kiecana, M. | +10

18

Prediction of Transporter-Mediated Rosuvastatin Hepatic Uptake Clearance and Drug Interaction in Humans Using Proteomics-Informed REF Approach

enthalten in: Drug metabolism and disposition: the biological fate of chemicals | 2021

von Kumar, V. | Yin, M. | Ishida, K. | +13

19

Evaluation of in vitro absorption, distribution, metabolism, and excretion and assessment of drug-drug interaction of rucaparib, an orally potent poly(ADP-ribose) polymerase inhibitor

enthalten in: Xenobiotica; the fate of foreign compounds in biological systems | 2020

von Liao, M. | Jaw-Tsai, S. | Beltman, J. | +3

20

Evaluation of absorption, distribution, metabolism, and excretion of [14C]-rucaparib, a poly(ADP-ribose) polymerase inhibitor, in patients with advanced solid tumors

enthalten in: Investigational new drugs | 2020

von Liao, M. | Watkins, S. | Nash, E. | +10